From the Blogposts » inbox

Vertex Shows Incredible Potential for Cystic Fibrosis

We’ve all seen the rise in the life expectancy of CFers over our lifetimes. Some are still with us, some are not, but the percentage of those living on and living more normal lives is on the rise every decade. New meds by Vertex are showing huge gains in lung function in many patients, and the drugs are in phase 3 trials, moving on to the next set of patients with even more decreased lung function soon.

New drugs for cystic fibrosis bring hope

Four drugs targeting the fundamental cause of CF made by Vertex Pharmaceuticals (VRTX) , Pharmaxis (AU:PXS) , PTC Therapeutics, and Inspire Pharmaceuticals (ISPH) are in phase 3 clinical trials